Skip to main content
Have a personal or library account? Click to login
Diagnostic performance of whole-body diffusion-weighted imaging for staging esophageal cancer: a comparative study with PET-CT Cover

Diagnostic performance of whole-body diffusion-weighted imaging for staging esophageal cancer: a comparative study with PET-CT

Open Access
|Jul 2026

References

  1. Zhang Y, He S, Chen J, Liu G, Luo Y, Song Y, et al. Artificial intelligence-assisted enhancement of prostate volume metrics in the diagnosis of clinically significant prostate cancer: a retrospective analysis. Quant Imaging Med Surg 2025; 15: 1641-52. doi: 10.21037/qims-24-1015
  2. Pozaruk A, Atamaniuk V, Pawar K, Carey A, Cheng J, Cholewa M, et al. Correlations between MR apparent diffusion coefficients and PET standard uptake values in simultaneous MR-PET imaging of prostate cancer. Int J Mol Sci 2025; 26: 905. doi: 10.3390/ijms26030905
  3. Dai X, Ye X, Ren J, Yang J, Zhou Y, Ma Z, et al. Construction of the preoperative staging prediction model for cervical cancer based on deep learning and MRI: a retrospective study. Front Oncol 2025; 15: 1557486. doi: 10.3389/fonc.2025.1557486
  4. Alkarn A, Stapleton LJ, Eleftheriou D, Stewart L, Chalmers GW, Hamed A, et al. Real-life pre-operative nodal staging accuracy in non-small cell lung cancer and its relationship with survival. Diagnostics (Basel) 2025; 15: 430. doi: 10.3390/diagnostics15040430
  5. Wang W, Ding Y, Jiang W, Li X. Can cervical lymph node metastasis increase the risk of distant metastasis in papillary thyroid carcinoma? Front Endocrinol (Lausanne) 2022; 13: 917794. doi: 10.3389/fendo.2022.917794
  6. Detterbeck FC, Woodard GA, Bader AS, Dacic S, Grant MJ, Park HS, et al. The proposed ninth edition TNM classification of lung cancer. Chest 2024; 166: 882-95. doi: 10.1016/j.chest.2024.05.026
  7. Ebner R, Sheikh GT, Brendel M, Ricke J, Cyran CC. ESR essentials: staging and restaging with FDG-PET/CT in oncology—practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging. Eur Radiol 2025; 35: 1894-902. doi: 10.1007/s00330-024-11094-8
  8. Dien Esquivel MF, AlMutawa A, Amirabadi A, Weitzman S, Buhtoiarov I, Doria AS, et al. Value of 18F-FDG PET/CT scans in staging and follow-up of pediatric Langerhans cell histiocytosis: comparison to CT and/or MRI. Children (Basel) 2025; 12: 1089. doi: 10.3390/children12081089
  9. Gitau SN, Shah J, Olwit W, Saeed S, Mansour MH, Makhdomi K. Supraclavicular nodal metastasis at primary staging of prostate cancer using (18)F-PSMA-1007 PET/CT. EJNMMI Rep 2025; 9: 9. doi: 10.1186/s41824-025-00241-z
  10. Pahk K, Ryu KJ, Joung C, Kwon HW, Lee S, Park H, et al. Metabolic activity of visceral adipose tissue is associated with metastatic status of lymph nodes in endometrial cancer: a (18)F-FDG PET/CT study. Int J Environ Res Public Health 2021; 19: 92. doi: 10.3390/ijerph19010092
  11. Salehjahromi M, Karpinets TV, Sujit SJ, Qayati M, Chen P, Aminu M, et al. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: proof of concept. Cell Rep Med 2024; 5: 101463. doi: 10.1016/j.xcrm.2024.101463
  12. Hussain D, Abbas N, Khan J. Recent breakthroughs in PET-CT multimodality imaging: innovations and clinical impact. Bioengineering (Basel) 2024; 11: 1213. doi: 10.3390/bioengineering11121213
  13. Frolli A, Varvello S, Balbo Mussetto A, Gottardi D, Bullo M, Marini S, et al. A radiation-free approach based on whole-body MRI shows high accuracy in the follow-up of lymphoma patients: a single-center retrospective study. J Clin Med 2024; 13: 3637. doi: 10.3390/jcm13133637
  14. Yoshida S, Takahara T, Arita Y, Sakaino S, Katahira K, Fujii Y. Whole-body diffusion-weighted magnetic resonance imaging: diagnosis and follow-up of prostate cancer and beyond. Int J Urol 2021; 28: 502-13. doi: 10.1111/iju.14497
  15. Mayer P, Kraft A, Witzel HR, Marnet N, Hörner N, Roth W, et al. Restricted water diffusion in diffusion-weighted magnetic resonance imaging in pancreatic cancer is associated with tumor hypoxia. Cancers (Basel) 2020; 13: 89. doi: 10.3390/cancers13010089
  16. Messina C, Bignone R, Bruno A, Bruno A, Bruno F, Calandri M, et al. Diffusion-weighted imaging in oncology: an update. Cancers (Basel) 2020; 12: 1493. doi: 10.3390/cancers12061493
  17. De Vuysere S, Vandecaveye V, De Bruecker Y, Carton S, Vermeiren K, Tollens T, et al. Accuracy of whole-body diffusion-weighted MRI in diagnosis, staging and follow-up of gastric cancer compared with CT: a pilot study. BMC Med Imaging 2021; 21: 18. doi: 10.1186/s12880-021-00550-2
  18. Albano D, Bruno A, Patti C, Micci G, Midiri M, Tarella C, et al. Whole-body magnetic resonance imaging in lymphoma: state of the art. Hematol Oncol 2020; 38: 12-21. doi: 10.1002/hon.2676
  19. Balestrucci G, Patanè V, Giordano N, Russo A, Urraro F, Nardone V, et al. Evolving paradigms in gastric cancer staging: from conventional imaging to advanced MRI and artificial intelligence. Diagnostics (Basel) 2026; 16: 284. doi: 10.3390/diagnostics16020284
  20. Kataoka M, Iima M, Miyake KK, Honda M. Multiparametric approach to breast cancer with emphasis on magnetic resonance imaging in the era of personalized breast cancer treatment. Invest Radiol 2024; 59: 26-37. doi: 10.1097/rli.0000000000001044
  21. Long Y, Shi R. Prognostic value of the cholesterol-dependent nutritional prognostic index in patients receiving adjuvant chemotherapy after radical esophageal cancer treatment. Eur J Med Res 2024; 29: 550. doi: 10.1186/s40001-024-02136-4
  22. Xie W, Bai X, Liu M, Shangguan H, Zhan Y, Wu X, et al. Benign and malignant bone lesion diagnosis based on self-supervised and radiomics fusion using SPECT/CT images. J Bone Oncol 2025; 55: 100723. doi: 10.1016/j.jbo.2025.100723
  23. Yu X, Wang J, Huang L, Xie L, Su Y. Predictive value of 18F-FDG PET/CT metabolic parameters for lymph node metastasis of non-small cell lung cancer. Biomark Med 2025; 19: 35-41. doi: 10.1080/17520363.2024.2443379
  24. Gao J, Shi Y, Niu R, Shao X, Shao X. Association analysis of maximum standardized uptake values based on (18)F-FDG PET/CT and EGFR mutation status in lung adenocarcinoma. J Pers Med 2023; 13: 396. doi: 10.3390/jpm13030396
  25. Li S, Liu J, Zhang Z, Wang W, Lu H, Lin L, et al. Added-value of 3D amide proton transfer MRI in assessing prognostic factors of cervical cancer: a comparative study with multiple model diffusion-weighted imaging. Quant Imaging Med Surg 2023; 13: 8157-72. doi: 10.21037/qims-23-324
  26. Yang C, Tian S, Du W, Liu M, Hu R, Gao B, et al. Glymphatic function assessment with diffusion tensor imaging along the perivascular space in patients with major depressive disorder and its relation to cerebral white-matter alteration. Quant Imaging Med Surg 2024; 14: 6397-412. doi: 10.21037/qims-24-510
  27. Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol 2017; 12: 36-42. doi: 10.21037/qims-24-510
  28. Duarte AL, Dias JL, Cunha TM. Pitfalls of diffusion-weighted imaging of the female pelvis. Radiol Bras 2018; 51: 37-44. doi: 10.1590/01003984.2016.0208
  29. Wang J, Chen B, Zhu J, Zhang J, Jiang R. Intelligent diagnosis value of preoperative T staging of colorectal cancer based on MR medical imaging. Front Genet 2023; 14: 1119990. doi: 10.3389/fgene.2023.1119990
  30. Fajardo A, Jara Noel K, Azevedo A, Marcotte E, Darvish M, Rocha G, et al. Concordance between clinical and pathological diagnosis of stromal corneal dystrophies in a large case series. Cornea 2025; 44: 1528-31. doi: 10.1097/ico.0000000000003980
  31. Zhong H, Huang Q, Zheng X, Wang Y, Qian Y, Chen X, et al. Generation of virtual monoenergetic images at 40 keV of the upper abdomen and image quality evaluation based on generative adversarial networks. BMC Med Imaging 2024; 24: 151. doi: 10.1186/s12880-024-01331-3
  32. Wang CY, Xu G, Gao C, Wang D. Esophageal metastases from primary lung cancer: a case report. J Med Case Rep 2021; 15: 265. doi: 10.1186/s13256-021-02765-x
  33. Sakata A, Fushimi Y, Oshima S, Uto M, Mineharu Y, Nakajima S, et al. RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology. Jpn J Radiol 2025; 43: 1557-74. doi: 10.1007/s11604-025-01821-6
  34. Matute-González M, Ronot M, Chernyak V, Sangro B, Rimola J. Response evaluation to systemic therapy in HCC: current challenges and future perspectives. Hepatology 2025. doi: 10.1097/hep.0000000000001621
  35. Zhao W, Huang J, Chen Y, Lu J, Hu W. The clinical value of CT and MRI in preoperative TNM staging of esophageal cancer. Front Med (Lausanne) 2025; 12: 1637764. doi: 10.21037/atm-20-2909
  36. Schmidlin EJ, Gill RR. New frontiers in esophageal radiology. Ann Transl Med 2021; 9: 904. doi: 10.3390/cancers17081351
  37. Haefliger L, Chapellier P, Vietti Violi N, Ledoux JB, Mantziari S, Schäfer M, et al. Advancing esophageal cancer staging and restaging: the role of MRI in precision diagnosis. Cancers (Basel) 2025; 17: 704. doi: 10.1007/s10388-019-00704-w
  38. Shuto K, Kono T, Shiratori T, Akutsu Y, Uesato M, Mori M, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET. Esophagus 2020; 17: 239-49. doi: 10.1016/j.ijrobp.2018.02.029
  39. Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, et al. Multimodal imaging of pathologic response to chemoradiation in esophageal cancer. Int J Radiat Oncol Biol Phys 2018; 102: 996-1001. doi: 10.3389/fonc.2022.844702
  40. Wang F, Guo R, Zhang Y, Yu B, Meng X, Kong H, et al. Value of (18)F-FDG PET/MRI in the preoperative assessment of resectable esophageal squamous cell carcinoma: a comparison with (18)F-FDG PET/CT, MRI, and contrast-enhanced CT. Front Oncol 2022; 12: 844702. doi: 10.3390/diagnostics15070908
  41. Kuhtić I, Mandić Paulić T, Kovačević L, Badovinac S, Jakopović M, Dobrenić M, et al. Clinical TNM lung cancer staging: a diagnostic algorithm with a pictorial review. Diagnostics (Basel) 2025; 15: 908. doi: 10.3390/diagnostics15070908
  42. Peng G, Zhan Y, Wu Y, Zeng C, Wang S, Guo L, et al. Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089). Front Oncol 2022; 12: 988859. doi: 10.3398/fonc.2022.988859
  43. Kommi S, Rallapeta RP, Subramanian BV, Yadagiri LA, Hulikal N, Chandramaliteeswaran C, et al. Utility of [18F]FDG-PET/CT in initial staging and management of patients with esophageal carcinoma: a tertiary care center experience. Indian J Nucl Med 2024; 39: 329-34. doi: 10.4103/ijnm.ijnm_118_23
  44. Yu J, Tan XG, Li F. Evaluation of the efficacy of (18)F-FDG PET-CT combined with CT in detecting lymph node metastasis in liver cancer. Front Oncol 2025; 15: 1636566. doi: 10.3389/fonc.2025.1636566
  45. Ingenerf M, Rübenthaler J, Wenter V, Zacherl M, Völter F, Winkelmann M, et al. Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor PET/CT. Front Oncol 2023; 13: 1194152. doi: 10.3389/fonc.2023.1194152
  46. Cattabriga A, Renzetti B, Galuppi F, Bartalena L, Gaudiano C, Brocchi S, et al. Multiparametric whole-body MRI: a game changer in metastatic prostate cancer. Cancers (Basel) 2024; 16: 2531. doi: 10.3390/cancers16142531
  47. Rezk M, Nasr I, Ali I, Abdelhamed H. Comparative study between (18)F FDG-PET/CT and whole-body MRI DWIBS in assessment of recurrent breast cancer (prospective, comparative, cross-sectional study design). Indian J Nucl Med 2019; 34: 1-9. doi: 10.4103/ijnm.IJNM_121_18
  48. Murakami T, Shimizu H, Nojima H, Shuto K, Usui A, Kosugi C, et al. Diffusion-weighted magnetic resonance imaging for the diagnosis of lymph node metastasis in patients with biliary tract cancer. Cancers (Basel) 2024; 16: 3143. doi: 10.3390/cancers16183143
  49. Jacobs MA, Macura KJ, Zaheer A, Antonarakis ES, Stearns V, Wolff AC, et al. Multiparametric whole-body MRI with diffusion-weighted imaging and ADC mapping for the identification of visceral and osseous metastases from solid tumors. Acad Radiol 2018; 25: 1405-14. doi: 10.1016/j.acra.2018.02.010
  50. Zhang B, Zhang L, Bian B, Lin F, Zhu Z, Wang J. Diagnostic value of WB-DWI versus (18)F-FDG PET/CT for the detection of multiple myeloma. Indian J Cancer 2023; 60: 303-9. doi: 10.4103/ijc.IJC_1129_20
  51. Yang H, Chen S, Qi M, Chen W, Kong Q, Zhang J, et al. Investigation of PET image quality with acquisition time/bed and enhancement of lesion quantification accuracy through deep progressive learning. EJNMMI Phys 2024; 11: 7. doi: 10.1186/s40658-023-00607-x
  52. Cong Q, Li G, Wang Y, Zhang S, Zhang H. DW-MRI for esophageal squamous cell carcinoma: correlations between ADC values with histologic differentiation and VEGF expression. Oncol Lett 2019; 17: 2770-6. doi: 10.3892/ol.2019.9934
  53. Yousafzai U, Najia J, Ali SL, Awais A, Amir H. Computer-aided discovery of novel COX-2 inhibitors for anti-inflammatory therapy using pharmacophore modelling, molecular docking, ADMET, and virtual screening. Adv Mod Biomed 2025; 1: 25-38. doi: 10.64229/md3sjz95
DOI: https://doi.org/10.2478/raon-2026-0037 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Submitted on: Feb 27, 2026
Accepted on: Jun 5, 2026
Published on: Jul 29, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Xiaohu Xu, Rong Yu, Qiulian Ma, Tingting Yin, Haisheng Chen, Ye Qian, Hong Li, Rongxing Qi, Yachun Xu, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.